Logo image of DLHC

DLH HOLDINGS CORP (DLHC) Stock Fundamental Analysis

NASDAQ:DLHC - Nasdaq - US23335Q1004 - Common Stock - Currency: USD

3.98  +0.04 (+1.02%)

Fundamental Rating

3

DLHC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. DLHC has a medium profitability rating, but doesn't score so well on its financial health evaluation. DLHC has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

DLHC had positive earnings in the past year.
DLHC had a positive operating cash flow in the past year.
In the past 5 years DLHC has always been profitable.
DLHC had a positive operating cash flow in each of the past 5 years.
DLHC Yearly Net Income VS EBIT VS OCF VS FCFDLHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.96%, DLHC is in line with its industry, outperforming 43.90% of the companies in the same industry.
DLHC has a Return On Equity of 5.71%. This is comparable to the rest of the industry: DLHC outperforms 48.78% of its industry peers.
DLHC has a Return On Invested Capital (7.20%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for DLHC is in line with the industry average of 13.48%.
The last Return On Invested Capital (7.20%) for DLHC is well below the 3 year average (11.89%), which needs to be investigated, but indicates that DLHC had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.96%
ROE 5.71%
ROIC 7.2%
ROA(3y)5.52%
ROA(5y)5.11%
ROE(3y)11.15%
ROE(5y)12.44%
ROIC(3y)11.89%
ROIC(5y)11.02%
DLHC Yearly ROA, ROE, ROICDLHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

DLHC has a Profit Margin (1.64%) which is in line with its industry peers.
DLHC's Profit Margin has declined in the last couple of years.
DLHC has a Operating Margin (6.10%) which is comparable to the rest of the industry.
DLHC's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 20.20%, DLHC is doing worse than 75.61% of the companies in the same industry.
DLHC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.1%
PM (TTM) 1.64%
GM 20.2%
OM growth 3Y-5.45%
OM growth 5Y-2.42%
PM growth 3Y-23.19%
PM growth 5Y-10.78%
GM growth 3Y-1.6%
GM growth 5Y-2.24%
DLHC Yearly Profit, Operating, Gross MarginsDLHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

2

2. Health

2.1 Basic Checks

DLHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, DLHC has more shares outstanding
DLHC has more shares outstanding than it did 5 years ago.
DLHC has a better debt/assets ratio than last year.
DLHC Yearly Shares OutstandingDLHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
DLHC Yearly Total Debt VS Total AssetsDLHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 1.65, we must say that DLHC is in the distress zone and has some risk of bankruptcy.
DLHC has a Altman-Z score of 1.65. This is in the lower half of the industry: DLHC underperforms 64.63% of its industry peers.
DLHC has a debt to FCF ratio of 17.00. This is a negative value and a sign of low solvency as DLHC would need 17.00 years to pay back of all of its debts.
DLHC has a Debt to FCF ratio of 17.00. This is in the lower half of the industry: DLHC underperforms 63.41% of its industry peers.
A Debt/Equity ratio of 1.21 is on the high side and indicates that DLHC has dependencies on debt financing.
The Debt to Equity ratio of DLHC (1.21) is worse than 78.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF 17
Altman-Z 1.65
ROIC/WACC0.72
WACC9.94%
DLHC Yearly LT Debt VS Equity VS FCFDLHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.04 indicates that DLHC should not have too much problems paying its short term obligations.
DLHC has a worse Current ratio (1.04) than 71.95% of its industry peers.
A Quick Ratio of 1.04 indicates that DLHC should not have too much problems paying its short term obligations.
DLHC has a worse Quick ratio (1.04) than 71.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
DLHC Yearly Current Assets VS Current LiabilitesDLHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2

3. Growth

3.1 Past

The earnings per share for DLHC have decreased strongly by -10.20% in the last year.
The Earnings Per Share has been growing slightly by 1.22% on average over the past years.
Looking at the last year, DLHC shows a decrease in Revenue. The Revenue has decreased by -3.02% in the last year.
The Revenue has been growing by 19.81% on average over the past years. This is quite good.
EPS 1Y (TTM)-10.2%
EPS 3Y-11.67%
EPS 5Y1.22%
EPS Q2Q%-46.67%
Revenue 1Y (TTM)-3.02%
Revenue growth 3Y17.18%
Revenue growth 5Y19.81%
Sales Q2Q%-7.22%

3.2 Future

The Earnings Per Share is expected to decrease by -50.33% on average over the next years. This is quite bad
The Revenue is expected to decrease by -17.14% on average over the next years. This is quite bad
EPS Next Y-126%
EPS Next 2Y-50.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-19.91%
Revenue Next 2Y-17.14%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DLHC Yearly Revenue VS EstimatesDLHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
DLHC Yearly EPS VS EstimatesDLHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

DLHC is valuated reasonably with a Price/Earnings ratio of 9.05.
Based on the Price/Earnings ratio, DLHC is valued cheaper than 87.80% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.88. DLHC is valued rather cheaply when compared to this.
The Forward Price/Earnings Ratio is negative for DLHC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 9.05
Fwd PE N/A
DLHC Price Earnings VS Forward Price EarningsDLHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 -30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DLHC indicates a rather cheap valuation: DLHC is cheaper than 91.46% of the companies listed in the same industry.
96.34% of the companies in the same industry are more expensive than DLHC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6
EV/EBITDA 5.35
DLHC Per share dataDLHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

A cheap valuation may be justified as DLHC's earnings are expected to decrease with -50.33% in the coming years.
PEG (NY)N/A
PEG (5Y)7.42
EPS Next 2Y-50.33%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DLHC!.
Industry RankSector Rank
Dividend Yield N/A

DLH HOLDINGS CORP

NASDAQ:DLHC (5/1/2025, 11:54:50 AM)

3.98

+0.04 (+1.02%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners76.45%
Inst Owner Change-1.06%
Ins Owners13.55%
Ins Owner Change4.38%
Market Cap57.27M
Analysts82.86
Price Target15.3 (284.42%)
Short Float %2.13%
Short Ratio3.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.32%
Min EPS beat(2)12.04%
Max EPS beat(2)42.6%
EPS beat(4)2
Avg EPS beat(4)0.29%
Min EPS beat(4)-43.98%
Max EPS beat(4)42.6%
EPS beat(8)5
Avg EPS beat(8)-0.15%
EPS beat(12)8
Avg EPS beat(12)9.62%
EPS beat(16)10
Avg EPS beat(16)5.62%
Revenue beat(2)0
Avg Revenue beat(2)-7.34%
Min Revenue beat(2)-8.25%
Max Revenue beat(2)-6.44%
Revenue beat(4)1
Avg Revenue beat(4)-4.7%
Min Revenue beat(4)-8.25%
Max Revenue beat(4)0.03%
Revenue beat(8)1
Avg Revenue beat(8)-4.41%
Revenue beat(12)2
Avg Revenue beat(12)-3.02%
Revenue beat(16)4
Avg Revenue beat(16)-2.42%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-18.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.44%
Valuation
Industry RankSector Rank
PE 9.05
Fwd PE N/A
P/S 0.15
P/FCF 6
P/OCF 5.32
P/B 0.51
P/tB N/A
EV/EBITDA 5.35
EPS(TTM)0.44
EY11.06%
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)0.66
FCFY16.66%
OCF(TTM)0.75
OCFY18.78%
SpS27.02
BVpS7.74
TBVpS-9.1
PEG (NY)N/A
PEG (5Y)7.42
Profitability
Industry RankSector Rank
ROA 1.96%
ROE 5.71%
ROCE 9.11%
ROIC 7.2%
ROICexc 7.21%
ROICexgc 107.06%
OM 6.1%
PM (TTM) 1.64%
GM 20.2%
FCFM 2.45%
ROA(3y)5.52%
ROA(5y)5.11%
ROE(3y)11.15%
ROE(5y)12.44%
ROIC(3y)11.89%
ROIC(5y)11.02%
ROICexc(3y)11.91%
ROICexc(5y)11.55%
ROICexgc(3y)142.07%
ROICexgc(5y)N/A
ROCE(3y)15.05%
ROCE(5y)13.95%
ROICexcg growth 3YN/A
ROICexcg growth 5Y-9.4%
ROICexc growth 3Y-17.74%
ROICexc growth 5Y-3.87%
OM growth 3Y-5.45%
OM growth 5Y-2.42%
PM growth 3Y-23.19%
PM growth 5Y-10.78%
GM growth 3Y-1.6%
GM growth 5Y-2.24%
F-Score7
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF 17
Debt/EBITDA 3.3
Cap/Depr 7.1%
Cap/Sales 0.31%
Interest Coverage 1.51
Cash Conversion 26.35%
Profit Quality 150.02%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 1.65
F-Score7
WACC9.94%
ROIC/WACC0.72
Cap/Depr(3y)6.77%
Cap/Depr(5y)4.74%
Cap/Sales(3y)0.2%
Cap/Sales(5y)0.14%
Profit Quality(3y)813.86%
Profit Quality(5y)632.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.2%
EPS 3Y-11.67%
EPS 5Y1.22%
EPS Q2Q%-46.67%
EPS Next Y-126%
EPS Next 2Y-50.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.02%
Revenue growth 3Y17.18%
Revenue growth 5Y19.81%
Sales Q2Q%-7.22%
Revenue Next Year-19.91%
Revenue Next 2Y-17.14%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.44%
EBIT growth 3Y10.79%
EBIT growth 5Y16.91%
EBIT Next Year31.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.43%
FCF growth 3Y-16.5%
FCF growth 5Y8.52%
OCF growth 1Y-57.6%
OCF growth 3Y-15.69%
OCF growth 5Y8.69%